BDSX Q1 2022 Earnings — Biodesix, Inc. Revenue & Financial Results | Market Cap Arena

BDSXBiodesix, Inc.

$151M

Q1 2022 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$7M-77.3% YoY

Gross Profit

$3M50.6% margin

Operating Income

-$14M-220.8% margin

Net Income

-$16M-238.0% margin

EPS (Diluted)

$-0.50

QoQ Revenue Growth

-9.4%

Cash Flow

Operating Cash Flow

-$13M

Free Cash Flow

-$13M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$62M

Total Liabilities

$54M

Stockholders' Equity

$8M

Cash & Equivalents

$16M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$7M	$29M	-77.3%
Gross Profit	$3M	$11M	-68.9%
Operating Income	-$14M	-$6M	-159.0%
Net Income	-$16M	-$7M	-123.9%

Revenue Segments

Diagnostic Tests

$6M86%

Service

$915,00014%